Trust, Innovation, and the Power of Patient Advocacy with Brendan Hayes - ASGCT's The Issue
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Trust, Innovation, and the Power of Patient Advocacy with Brendan Hayes - ASGCT's The Issue
-
Narrated by:
-
By:
About this listen
Join host Emily Walsh Martin and guest Brendan Hayes, senior director of education and innovative therapies at the National Bleeding Disorders Foundation, formerly known as the National Hemophilia Foundation. for an illuminating conversation about trust, innovation, and the power of patient advocacy in advancing cell and gene therapies.
Together, they dive into how patient communities shape the development of new therapies, the historical context that influences decision-making in clinical trials, and the unique considerations facing those who might choose to pursue cell and gene therapies.
You can also hear Brendan in a panel discussion titled The Journey from Early-stage Trials to Approval at ASGCT’s Empowering Patients 2025: A Cell and Gene Therapies Summit. Hosted live on March 12 and 13, you can register for this free, patient-centered virtual event by visiting ASGCT.org/EP2025.
Music by: https://www.steven-obrien.net/
--------------------------
Bright New Morning - Steven O'Brien
(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.